Skip to main content

Table 2 Periprocedural details and discharge medication, median (IQR), or N (%)

From: Culprit-only versus staged complete revascularization for patients with ST-segment elevation myocardial infarction and Multivessel disease: a retrospective cohort study

 

CR, n = 382

SR, n = 220

P

Percutaneous coronary intervention

   

TIMI flow grade 0/1 on arrival

288 (75.4)

165 (75.0)

0.914

TIMI flow grade 3 post-PCI

375 (98.2)

218 (99.1)

0.369

Number of stents

1 (1,2)

3 (2,4)

<0.001

Stent type

  

0.211

No stenting

9 (2.4)

1 (0.5)

 

Bare metal

2 (0.5)

1 (0.5)

 

Drug-eluting

371 (97.1)

218 (99.1)

 

Total stent length for all lesions treated, mm

36 (24,57)

79 (54,109)

<0.001

Lesion site in culprit vessel

  

0.700

Left anterior descending artery

169 (44.2)

95 (43.2)

 

Left circumflex artery

48 (12.6)

33 (15.0)

 

Right coronary artery

165 (43.2)

92 (41.8)

 

Thrombus aspiration catheter used

55 (14.4)

27 (12.3)

0.464

Use of glycoprotein IIb/IIIa inhibitor

142 (37.2)

127 (42.3)

0.217

Medical treatment at discharge

   

Aspirin

376 (98.4)

217 (98.6)

0.840

Clopidogrel

373 (97.6)

213 (96.8)

0.544

Ticagrelor

5 (1.3)

5 (2.3)

0.373

Statin

358 (93.7)

203 (92.3)

0.498

Beta-blockers

224 (58.6)

115 (52.1)

0.121

Angiotensin-converting enzyme inhibitors/Angiotensin receptor blockers

224 (58.6)

133 (60.5)

0.662

Calcium-channel blocker

24 (6.3)

9 (4.1)

0.255

Nitrate

39 (10.2)

16 (7.3)

0.228

Nicorandil

20 (5.2)

6 (2.7)

0.145